Data dictionary: Melanoom - DMTR: Difference between revisions

From Beacon
No edit summary
No edit summary
 
(4 intermediate revisions by 3 users not shown)
Line 1: Line 1:
<span style="display:none">forresearchers</span>
<span style="display:none">thenetherlandscountry</span>
Go back to [[Dutch Institute for Clinical Auditing Databases (DICA) (The Netherlands)]] page.
Go back to [[Dutch Institute for Clinical Auditing Databases (DICA) (The Netherlands)]] page.


Line 28: Line 30:
| Patient Type
| Patient Type
|-
|-
| Location of Primary Tumor
| Location of Primary Tumour
|-
|-
| Pathology (PA) Result Known?
| Pathology (PA) Result Known?
Line 37: Line 39:
|}
|}


'''Table 3:''' Tumor Characteristics and Diagnosis.
'''Table 3:''' Tumour Characteristics and Diagnosis.
{| class="wikitable"
{| class="wikitable"
! Variables
! Variables
Line 63: Line 65:
| Distant Metastases
| Distant Metastases
|-
|-
| Locations of Current Tumor Presentation
| Locations of Current Tumour Presentation
|}
|}


Line 132: Line 134:
| Metastases Staging?
| Metastases Staging?
|-
|-
| Tumor Stage Before (Neo)adjuvant Treatment
| Tumour Stage Before (Neo)adjuvant Treatment
|-
|-
| Imaging: CT Thorax and/or Abdomen, PET-CT, MRI or CT of the Brain
| Imaging: CT Thorax and/or Abdomen, PET-CT, MRI or CT of the Brain
Line 138: Line 140:
| Lab Tests: S100, LDH Levels
| Lab Tests: S100, LDH Levels
|-
|-
| Locations of Current Tumor Presentation Metastases Confirmed?
| Locations of Current Tumour Presentation Metastases Confirmed?
|-
|-
| In-transit Metastases and/or Satellitosis
| In-transit Metastases and/or Satellitosis
Line 149: Line 151:
! Variables
! Variables
|-
|-
| Histology of Primary Tumor Examined
| Histology of Primary Tumour Examined
|-
|-
| Revision Histology of Primary Tumor
| Revision Histology of Primary Tumour
|-
|-
| Histology and/or Cytology of Current Tumor Presentation Available
| Histology and/or Cytology of Current Tumour Presentation Available
|-
|-
| Genmutation BRAF, NRAS, KIT, GNAQ, GNA11 Known/Determined
| Genmutation BRAF, NRAS, KIT, GNAQ, GNA11 Known/Determined

Latest revision as of 17:43, 4 December 2025

forresearchers thenetherlandscountry Go back to Dutch Institute for Clinical Auditing Databases (DICA) (The Netherlands) page.

This is a summary of the variables available in the database. You can download the complete data dictionary. Click here to learn more.

Table 1: Basic Patient Information.

Variables
Healthcare Facility
Unique Patient Number
Date of Birth
Gender
Date of Death (if applicable)

Table 2: Melanoma Center Details.

Variables
Hospital Patient Number
Date of First Disease Presentation Diagnosis of Melanoma
Patient Type
Location of Primary Tumour
Pathology (PA) Result Known?
PA Number (TJJ-CCCCCC)
PA Laboratory

Table 3: Tumour Characteristics and Diagnosis.

Variables
Type of Eye Melanoma
Type of Melanoma
Breslow Thickness in Millimeters (unknown = 999)
Ulceration
Satellite / In-transit Metastasis
Sentinel Node Procedure Performed at Primary Diagnosis?
Capsule Rupture Occurrence?
Sentinel Node Diameter
Primary Melanoma Regression?
Lymph Node Metastases (macroscopic)
Distant Metastases
Locations of Current Tumour Presentation

Table 4: Comorbidities.

Variables
Cardiac
Vascular
Diabetes
Pulmonary
Neurological/Psychiatric
Gastrointestinal
Urogenital
Thrombotic
Musculoskeletal
Endocrine Disorders
Infectious Diseases
Malignancy
Autoimmune Disorders
Organ Transplantation
Other Comorbidities

Table 5: Medications Usage.

Variables
Analgesics: Start and Stop Dates, Reason for Use
Antibiotics: Start and Stop Dates, Reason for Use
Antiviral Agents: Start and Stop Dates, Reason for Use
Anticoagulants and Thrombolytics: Start and Stop Dates, Reason for Use
Anticonvulsants: Start and Stop Dates, Reason for Use
Antiemetics: Start and Stop Dates, Reason for Use
Anti-inflammatory Drugs: Start and Stop Dates, Reason for Use
Corticosteroids: Start and Stop Dates, Reason for Use
Imuran (Azathioprine): Start and Stop Dates, Reason for Use
Interferon: Start and Stop Dates, Reason for Use

Table 6: Metastases and Staging.

Variables
Metastases Staging?
Tumour Stage Before (Neo)adjuvant Treatment
Imaging: CT Thorax and/or Abdomen, PET-CT, MRI or CT of the Brain
Lab Tests: S100, LDH Levels
Locations of Current Tumour Presentation Metastases Confirmed?
In-transit Metastases and/or Satellitosis
Recurrent Primary Melanoma

Table 7: Histology and Genetics.

Variables
Histology of Primary Tumour Examined
Revision Histology of Primary Tumour
Histology and/or Cytology of Current Tumour Presentation Available
Genmutation BRAF, NRAS, KIT, GNAQ, GNA11 Known/Determined
Other Detected Genmutations